Larimar Therapeutics Inc.

LRMR | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.85

+$0.02 (+0.52%)

Sep 22, 2026, 12:45 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-165.67M	-80.6M	-36.95M	-35.36M	-50.64M	-42.48M
Depreciation & Amortization	350K	318K	311K	318K	326K	155K
Stock-Based Compensation	7M	8.8M	7.62M	6.62M	5.47M	2.16M
Other Working Capital	44.31M	5.03M	-2.11M	1.64M	3.72M	1.25M
Other Non-Cash Items	-1.98M	-5.45M	-1.93M	-820K	-15K	10K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	47.1M	6.18M	-2.51M	1.67M	2.75M	-2.04M
Operating Cash Flow	-113.2M	-70.76M	-33.46M	-27.57M	-42.11M	-42.2M
Capital Expenditures	-91K	-515K	-164K	-100K	-333K	-62K
Cash Acquisitions	n/a	n/a	n/a	90.86K	-24.5K	-1.3M
Purchase of Investments	-83.6M	-227.87M	-101.23M	-133.61M	-8.25M	-24.49M
Sales Maturities Of Investments	184M	143M	134.75M	42.75M	32.75M	1M
Other Investing Acitivies	n/a	n/a	n/a	-90.86K	24.5K	41.93M
Investing Cash Flow	100.31M	-85.39M	33.35M	-90.96M	24.17M	17.09M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	77K	n/a	n/a	n/a	18M
Financial Cash Flow	65.09M	161.88M	30K	75.26M	19.89M	93.59M
Net Cash Flow	52.19M	5.74M	-76K	-43.27M	1.95M	68.48M
Free Cash Flow	-113.29M	-71.28M	-33.62M	-27.67M	-42.44M	-42.26M
Adj. Free Cash Flow	-120.3M	-80.07M	-41.24M	-34.29M	-47.91M	-44.42M
Maintenance CapEx	-91K	-318K	-164K	-100K	-326K	-62K
Growth CapEx	n/a	-197K	n/a	n/a	-7K	n/a
Owner Earnings	-113.29M	-71.08M	-33.62M	-27.67M	-42.43M	-42.26M